State Ledger
Company profile

SCYNEXIS INC CIK 1178253

Ticker
SCYX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Jersey City, NJ 07302-6548
Fiscal year end
2025 (FY)
Market Data
Close
$4.04
Change
-$0.02
Change %
-0.49%
Volume
1,364

SCYX · trading date Oct 12, 2026 · previous close $4.06 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$20.60M
Net income
-$8.61M
Total assets
$59.03M
Total liabilities
$9.65M
Stockholders' equity
$49.38M
Cash & equivalents
$21.26M
Operating income
-$16.07M
Operating cash flow
-$5.28M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-04. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-78.0%
Net margin
-41.8%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
16.4%
Equity / assets
83.6%
CapEx / revenue
—
Operating cash flow / net income
0.61×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $20.60M -$8.61M $59.03M $9.65M $49.38M
2024 $3.75M -$21.29M $90.64M $35.57M $55.08M
2023 $140.14M $67.04M $128.41M $55.45M $72.96M
2022 $5.09M -$62.81M $87.81M $84.58M $3.23M
2021 $13.16M -$32.87M $119.84M $78.58M $41.26M
Company Details
SIC code
2834
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-11
Financials filed via
Form 10-K
filed 2026-03-04

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Jersey City, NJ 07302-6548
1 EVERTRUST PLAZA
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies